Flow cytometry and immunofluorescence microscopy was used to validate expression of the characteristic BC markers KRT5 and p63 (Fig. 3a and Supplementary Fig. 5), and typical BC morphology was demonstrated with Airyscan (Fig. 3b). This evidence concerns the gene KRT5 and breast cancer.